Home Synthesis of New TGX-221 Analogs
Article
Licensed
Unlicensed Requires Authentication

Synthesis of New TGX-221 Analogs

  • Chunjing Liu EMAIL logo , Benyi Li and Lester Mitscher
Published/Copyright: June 2, 2014
Become an author with De Gruyter Brill

TGX-221 is a potent phosphoinositide 3-kinase (PI3K)β inhibitor that has great therapeutic potential to treat prostate cancer. Chemical modification of TGX-221 at positions 2 and 9 was made. Five new TGX-221 analogs with different heterocyclic substituents of morpholine, 1-methylpiperazine, aniline, and thiazole-2-amine at positions 2 and 9 were synthesized. Parallel synthetic methods were employed in SN2 replacement reactions at positions 2 and 9 of TGX-221.

Graphical Abstract

 Synthesis of New TGX-221 Analogs

Synthesis of New TGX-221 Analogs

Received: 2014-3-31
Published Online: 2014-6-2
Published in Print: 2014-7-1

© 1946 – 2014: Verlag der Zeitschrift für Naturforschung

Downloaded on 6.11.2025 from https://www.degruyterbrill.com/document/doi/10.5560/znb.2014-4081/html
Scroll to top button